Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Onset, duration, and persistence of taste and smell changes and other COVID-19 symptoms: longitudinal study in Israeli patients

View ORCID ProfileHadar Klein, Kim Asseo, View ORCID ProfileNoam Karni, View ORCID ProfileYuval Benjamini, View ORCID ProfileRan Nir-Paz, View ORCID ProfileMordechai Muszkat, View ORCID ProfileSarah Israel, View ORCID ProfileMasha Y. Niv
doi: https://doi.org/10.1101/2020.09.25.20201343
Hadar Klein
1The Institute of Biochemistry, Food and Nutrition, The Hebrew University, Rehovot, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Hadar Klein
Kim Asseo
1The Institute of Biochemistry, Food and Nutrition, The Hebrew University, Rehovot, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Noam Karni
2Department of Medicine, Hadassah University Hospital, Mt. Scopus Campus, Jerusalem, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Noam Karni
Yuval Benjamini
3Department of Statistics and Data Science, The Hebrew University, Mt. Scopus Campus, Jerusalem, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yuval Benjamini
Ran Nir-Paz
4Department of Clinical Microbiology and Infectious Diseases, Hadassah-Hebrew University medical center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ran Nir-Paz
Mordechai Muszkat
2Department of Medicine, Hadassah University Hospital, Mt. Scopus Campus, Jerusalem, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mordechai Muszkat
Sarah Israel
2Department of Medicine, Hadassah University Hospital, Mt. Scopus Campus, Jerusalem, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sarah Israel
Masha Y. Niv
1The Institute of Biochemistry, Food and Nutrition, The Hebrew University, Rehovot, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Masha Y. Niv
  • For correspondence: masha.niv@mail.huji.ac.il
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Objectives The multifaceted manifestation of COVID-19 requires longitudinal characterization of symptoms, to aid with screening and disease management.

Methods Phone interviews and follow-ups were completed with 112 mostly mild COVID-19 RT-PCR-positive adult patients, over a six-months period.

Results More than one symptom at disease onset was experienced by ∼70% of the patients. About 40% of the patients experienced fever, dry cough, headache, or muscle ache as the first symptom. Fatigue, if reported, usually was the first to appear. Smell and taste changes were experienced 3.9 ± 5.4 and 4.6 ± 5.7 days (mean ± SD) after disease onset and emerged as first symptom in 15% and 18% of patients, respectively. Fever had the shortest duration (5.8 ± 8.6 days), and taste and smell changes were the longest-lasting symptoms (17.2 ± 17.6 and 18.9 ± 19.7 days, durations censored at 60 days). Longer smell recovery correlated with smell change severity. Cough, taste change and smell change persisted after negative RT-PCR tests (in 20%, 26% and 29% of the patients in total). At six-months follow-up, 46% of the patients had at least one unresolved symptom, most commonly fatigue (21%), chemosensory changes (14%) or breath difficulty (9%).

Conclusions More than one symptom typically occurred at disease onset. Chemosensory changes and cough persisted after negative RT-PCR in a quarter of the patients. Almost half of the patients reported at least one unresolved symptom at six-months follow up, mainly fatigue, smell changes and breath difficulty. Our findings highlight the prevalence of long-lasting effects of COVID-19.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

MYN is supported by Israel Science Foundation (ISF) grant #1129/19. HK is a recipient of the Uri Zehavi Scholarship. This work was supported in part by Edmond de Rothschild foundation.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was conducted in accordance with Helsinki committee and the required ethics approval was granted (reference number HMO-0236-20).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Follow up of patients extended to 6 months, analyses, figures, supplemental and conclusions updated accordingly.

Data Availability

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.

  • LIST OF ABBREVIATIONS

    CDC
    Centers for Disease Control and Prevention
    SARS-CoV-2
    Severe Acute Respiratory Syndrome Coronavirus 2
    SD
    Standard Deviation
    GCCR
    Global Consortium for Chemosensory Research
    RT-PCR
    Real Time Polymerase Chain Reaction
    URI
    Upper Respiratory tract Infections
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
    Back to top
    PreviousNext
    Posted October 17, 2020.
    Download PDF

    Supplementary Material

    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Onset, duration, and persistence of taste and smell changes and other COVID-19 symptoms: longitudinal study in Israeli patients
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Onset, duration, and persistence of taste and smell changes and other COVID-19 symptoms: longitudinal study in Israeli patients
    Hadar Klein, Kim Asseo, Noam Karni, Yuval Benjamini, Ran Nir-Paz, Mordechai Muszkat, Sarah Israel, Masha Y. Niv
    medRxiv 2020.09.25.20201343; doi: https://doi.org/10.1101/2020.09.25.20201343
    Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
    Citation Tools
    Onset, duration, and persistence of taste and smell changes and other COVID-19 symptoms: longitudinal study in Israeli patients
    Hadar Klein, Kim Asseo, Noam Karni, Yuval Benjamini, Ran Nir-Paz, Mordechai Muszkat, Sarah Israel, Masha Y. Niv
    medRxiv 2020.09.25.20201343; doi: https://doi.org/10.1101/2020.09.25.20201343

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Infectious Diseases (except HIV/AIDS)
    Subject Areas
    All Articles
    • Addiction Medicine (174)
    • Allergy and Immunology (419)
    • Anesthesia (97)
    • Cardiovascular Medicine (894)
    • Dentistry and Oral Medicine (166)
    • Dermatology (101)
    • Emergency Medicine (257)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (404)
    • Epidemiology (8744)
    • Forensic Medicine (4)
    • Gastroenterology (403)
    • Genetic and Genomic Medicine (1844)
    • Geriatric Medicine (175)
    • Health Economics (386)
    • Health Informatics (1281)
    • Health Policy (642)
    • Health Systems and Quality Improvement (488)
    • Hematology (206)
    • HIV/AIDS (387)
    • Infectious Diseases (except HIV/AIDS) (10519)
    • Intensive Care and Critical Care Medicine (564)
    • Medical Education (193)
    • Medical Ethics (52)
    • Nephrology (216)
    • Neurology (1744)
    • Nursing (100)
    • Nutrition (264)
    • Obstetrics and Gynecology (342)
    • Occupational and Environmental Health (457)
    • Oncology (959)
    • Ophthalmology (279)
    • Orthopedics (107)
    • Otolaryngology (174)
    • Pain Medicine (117)
    • Palliative Medicine (41)
    • Pathology (262)
    • Pediatrics (553)
    • Pharmacology and Therapeutics (264)
    • Primary Care Research (218)
    • Psychiatry and Clinical Psychology (1836)
    • Public and Global Health (3962)
    • Radiology and Imaging (649)
    • Rehabilitation Medicine and Physical Therapy (340)
    • Respiratory Medicine (532)
    • Rheumatology (214)
    • Sexual and Reproductive Health (178)
    • Sports Medicine (165)
    • Surgery (196)
    • Toxicology (37)
    • Transplantation (105)
    • Urology (78)